Which condition is NOT treated by Ganciclovir?

Ganciclovir is primarily utilized for the management of cytomegalovirus (CMV) infections, such as CMV retinitis, which is a common complication in individuals with compromised immune systems, such as those with HIV or other immunosuppressive conditions. It acts by inhibiting viral DNA synthesis, making it effective against certain herpes viruses, specifically CMV.

Regarding the other conditions, Ganciclovir is also used to treat Herpes Simplex Virus (HSV) keratitis, albeit it is more commonly compared to acyclovir for this purpose. However, it is the treatment of choice for CMV-related conditions. In the context of viral infections, Ganciclovir has broad antiviral properties against herpesviruses. However, it is not typically indicated for retinal infections specifically associated with HIV nor for HIV itself, as these conditions may require different treatment approaches tailored to the underlying pathology of HIV.

Therefore, the scenario that identifies HIV retinitis as a condition treated with Ganciclovir is not supported, as the primary focus of treatment for HIV-related complications may involve antiretroviral therapy rather than targeting with Ganciclovir. This distinction is why identifying HIV retinitis as a condition treated by Ganc